ENCORA THERAPEUTICS
Encora is a MIT spin-off company innovating solutions for neurological movement disorders.
ENCORA THERAPEUTICS
Industry:
Health Care Information Technology Medical Medical Device Personal Health
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.encoratherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
1.7 M USD
Technology used in webpage:
Google Apps For Business Unified Layer Google DNS Google Domains Google Cloud DNS BlueHost
Current Employees Featured
Kyle Pina Co-Founder @ Encora Therapeutics
Co-Founder
2017-09-01
Daniel Carballo CEO & Co-Founder @ Encora Therapeutics
CEO & Co-Founder
2018-01-01
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Encora Therapeutics
MIT delta v
MIT delta v investment in Non Equity Assistance - Encora Therapeutics
MIT Sandbox
MIT Sandbox investment in Non Equity Assistance - Encora Therapeutics
Innospark Ventures
Innospark Ventures investment in Pre Seed Round - Encora Therapeutics
Good Growth Capital
Good Growth Capital investment in Convertible Note - Encora Therapeutics
77
77 investment in Pre Seed Round - Encora Therapeutics
Official Site Inspections
http://www.encoratherapeutics.com Semrush global rank: 5.13 M Semrush visits lastest month: 1.59 K
- Host name: box5709.bluehost.com
- IP address: 162.241.252.116
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Encora Therapeutics"
Home - Encora Therapeutics
The Breakthrough Device Program was created to accelerate the path to market for innovative medical devices which demonstrate the promise to substantially improve the standard of care …See details»
Encora Therapeutics - Crunchbase Company Profile & Funding
AI-powered Smart Wearable Device for Tremor Reduction: A wearable device that senses tremor severity in real time and introduces dynamic personalized vibro-tactile stimulus to the wrist to …See details»
Encora Therapeutics - LinkedIn
Encora Therapeutics | 1,498 followers on LinkedIn. Restoring Independence | We’re 4 MIT engineers who started Encora to research wearable solutions for patients with movement …See details»
Encora Therapeutics - PitchBook
Encora Therapeutics General Information Description. Developer of neurostimulation devices designed for patients with neurological movement …See details»
Encora Therapeutics - Forbes
Feb 28, 2025 Daniel Carballo, Allison Davanzo and Kyle Pina are cofounders of Encora Therapeutics, which is developing a smart wearable device that delivers customized vibrations to provide relief from tremors ...See details»
Encora Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Encora Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news.See details»
Encora Therapeutics - The Org
We’re 4 MIT engineers who started Encora to research wearable solutions for patients with movement disorders. We’re leveraging advances in wearable technology, signal processing, …See details»
Encora Therapeutics Overview | SignalHire Company Profile
Organization Website: encoratherapeutics.com : Social Links: Phone Number: 1-314-451-1484: Encora Therapeutics industries Medtech, Health Care Equipment, Health Care Technology: …See details»
Encora Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Encora Therapeutics - VentureRadar
Website: http://encoratherapeutics.com. Develops a non-invasive wearable device using vibratory stimulation for effective, safe relief of acute hand tremors without ...See details»
Encora Therapeutics - Creative Destruction Lab
Encora is developing a wearable device that uses non-invasive, vibratory stimulation to the wrist for acute hand tremor relief. Over eight million Americans suffer from debilitating hand tremors but are not adequately served by the …See details»
Encora Therapeutics Company Profile | Management and
Www.encoratherapeutics.com . Encora Therapeutics Profile and History. Encora is working on building affordable, non-invasive neurostimulation devices for those affected by movement …See details»
Encora Therapeutics - Overview, News & Similar companies
Encora Therapeutics contact info: Phone number: (314) 451-1484 Website: www.encoratherapeutics.com What does Encora Therapeutics do? Encora is working on …See details»
Encora Inc’s Competitors, Revenue, Number of Employees ... - Owler
Encora Inc’s Profile, Revenue and Employees. Encora is a medical device company that develops and commercializes non-invasive neurostimulation devices for the treatment of Parkinson's …See details»
Nextsource | Company Profile | Encora Therapeutics
Explore the company profile of Encora Therapeutics (encoratherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Encora Therapeutics, Inc.:Company Profile & Technical Research ...
Https://encoratherapeutics.com. Encora Therapeutics is a company that provides Movement disorders and more. Encora Therapeutics is headquartered in United States Massachusetts. …See details»
Encora Therapeutics - Products, Competitors, Financials, …
Rune Labs. Rune Labs is a software and data analytics company that focuses on neurology within the healthcare sector. The company offers a care delivery ecosystem for Parkinson’s disease, …See details»
Encora Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Encora Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Encora Therapeutics | VentureRadar
Similar Companies: Plexaa United Kingdom Privately Held Plexaa is a medtech company focused on improving surgical outcomes for breast cancer patients. Specializing in solutions to prevent …See details»
—Subsequent clinical trials expected to begin in 2021— Adults …
D e b i l i ta n g sy m pto m s .3 H a n d t re m o r m a ke s co u nt l e s s eve r yd ay ta s ks s u c h a s w r i n g , u s i n g a co m p u te r, d re s s i n g ,See details»